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Abstract
Introduction: Low-level laser therapy (LLLT) has been used as an effective therapeutic modality 
since the mid-1960s. Although there have been several clinical studies using LLLT in wound healing, 
especially diabetic, pressure and venous ulcers, there are few reports of using this technique in 
burn ulcers. Autologous fibroblast transplantation is a novel treatment for patients with burns 
or venous ulcers. In this study for the first time, we used LLLT along with autologous fibroblast 
skin transplantation to treat grade 3 burn ulcers in diabetic patients. This case series describes the 
successful management of grade 3 burn ulcers in 10 diabetic patients using autologous fibroblast 
transplantation along with LLLT.
Methods: After the approval of the Tehran University Ethics Committee (IR.TUMS.REC.1394.1683) 
and the Iran Registry of Clinical Trials (IRCT2016050226069N3), 10 diabetic patients with 10 
grade 3 burn ulcers, who were a candidate for skin graft surgery, entered the study. Donor skin 
was biopsied using a 3 mm punch. Fibroblasts were extracted and cultured in vitro in the GMP 
Technique laboratory. The patients were treated using LLLT in 3-4 weeks during the time that 
fibroblast cultures became ready to use. Laser irradiation was done using red light, 650 nm, 150 
mW, 1 J/cm2 for the bed of the ulcer and infra-red light 808 nm, 200 mW, 6 J/cm2 for the margins 
every other day for 10 sessions.
Results: The mean wound size before treatment was 16.28 cm2. All patients’ burn wounds healed 
completely after 10-12 weeks.
Conclusion: We conclude that this method can be used as an effective method for treating large 
wounds, especially in complicated patients including the diabetics.
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Introduction
Millions of patients are hospitalized due to burn ulcers 
and more than 300 000 of them die of complications.1 The 
healing process in these patients is complicated due to 
poor blood supply and infection.2 Spontaneous healing 
of these ulcers may cause scar formation and the patients 
may need surgical treatments including auto or allograft 
which may have limitations because of antigenicity or 
insufficient donor skin.3
Several therapeutic modalities have been introduced 
for accelerating the closure time and decreasing scar 
formation of these ulcers, including different kinds 
of dressings, growth factors, and surgical methods.4,5 
Autologous fibroblast or keratinocyte transplantation is 
one of the novel treatments for patients with burns or 
venous ulcers.6-8 Studies show that activated autologous 
fibroblasts can provide the fibroblast growth factor, 
the platelet-derived growth factor, and the vascular, 
endothelial growth factor and have a significant effect 
on extracellular matrix formation, differentiation, and 
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epidermal proliferation.5,9 A major problem is that 
cultivating sufficient amounts of fibroblasts requires at 
least 3-4 weeks10 and burn areas need therapeutic supports 
during this time. 
Low-level laser therapy (LLLT) has been used as an 
effective, safe, and non-invasive treatment for wound 
healing. Low-power lasers have no thermal effects 
and can accelerate the healing process by stimulating 
microcirculation, fibroblast proliferation, granulation 
tissue formation, collagen synthesis, and immune system 
modulation. Studies show that laser therapy improves 
cellular metabolic processes and the regenerative capacity 
of injured tissues.11-13 
Our previous reports manifested the significant effects 
of using LLLT on the treatment of foot ulcers, burn ulcers, 
neuropathy, and the metabonomic of diabetic patients,14-18 
increasing growth factors,19 the improvement of healing 
after cesarean surgery20 and coronary bypass grafting.21
In this study, we evaluated two modern therapies, LLLT 
for phase 1 (the first 3-4 weeks that fibroblast culture 
lasts) and autologous fibroblast transplantation as phase 
2 in patients with grade 3 burn ulcers. 
Methods
The diabetic patients (30-68 years old) with chronic grade 
3 burn ulcers (according to the University of Texas wound 
classification system22) who were hospitalized in Shahid 
Motahari Burn center entered the study. They had received 
classic diabetic wound care including glycemic control, 
topical and oral antibiotic therapy for the infected wounds 
according to wound culture, offloading and surgical 
debridement, but they had no sign of improvement after 
6 weeks. The patients’ primary data are shown in Table 1.
The exclusion criteria were pregnancy, photosensitivity, 
chronic disease that needed medication, and malignancy. 
After filling the questionnaire and the informed consent, 
standard photographs were taken of all patients using an 
iPhone 5 camera without flash. For obtaining fibroblast, 
a 3 mm punch was used for a skin biopsy from the retro-
auricular area after anesthesia with lidocaine 2%. The skin 
biopsies were placed in sterile culture media (RPMI) with 
100U/ML penicillin + 100U/ML streptomycin (ATOCEL, 
Austria, ATRA-010) and were transferred to a clean room 
of the skin and stem cell research center for culturing 
using GMP techniques. For 3-4 weeks, LLLT was done 
using red light (Canadian Optic Laser Center, COL Laser, 
Canada), 650 nm, 150 mW, 1 J/cm2 for the bed of the ulcer 
and infra-red light 808 nm, 200 mW, 6 J/cm2 (Azor 2k 
Laser, Russia) for the margins every other day. 
Cell Culture 
The biopsied skins were washed with DMEM (ATOCEL, 
Austria ATCDH883) plus penicillin and streptomycin 
(ATOCEL, Austria, ATRA-010) three times, the fatty 
layers of the skins were removed, and the skins were cut 
into small pieces using a scalpel and were transferred into 
a 15 mL round-bottomed tube. 0.1% collagenase type 1 
(ATOCEL, Austria) was added and incubated 2 hours 
at 37°C, Co2 5% and 95% humidity. After shaking and 
centrifuging at 1000 rpm for 5 minutes, sediment was 
added to 6 well plates and 1 mL high glucose DMEM 
(ATOCEL, Austria, ATCDH883), supplemented with 
10% bovine serum, was added to each well. The medium 
was changed to a fresh one every 2 days. Upon reaching 
80%-90% confluency, the cells were detached using 
trypsin 0.25% (ATOCEL, Austria, ATRE 10810) and 
sub-cultured in a 25 cm2 cell flask. The plates were 
microscopically verified to guarantee that the cells were 
confluent and there was no contamination. The cultured 
cells were tested for mycoplasma, fungi and bacterial 
contamination. After 3-4 weeks, 20 million fibroblasts 
were isolated and suspended in 1 mL phosphate-buffered 
saline (PBS) for transplantation.
Transferring Cells to the Wound Area
We used trichloroacetic acid (TCA) 50% for chemical 
debridement of hyperkeratotic surrounding tissue.23 Then 
the bases of ulcers were abraded by a surgical scalpel No. 
15 to create pinpoint bleeding. After washing the wound 
surface with normal saline, a thin layer of fibroblast 
suspension was applied to the base of the ulcer using a 
sterile sampler and its surface was covered by Vaseline 
gauze and a Mepitel (Molnlycke health care, Sweden) 
dressing and a Tegaderm (3M, America) dressing over 
the Vaseline gauze to fix the cells. The Tegaderm dressing 
has a thin polyurethane membrane coated with acrylic 
adhesive. To prevent secondary infection, cephalexin 500 
mg was prescribed four times a day for seven days. The 
dressing was removed on day seven. The patients were 
evaluated every other day until complete closure of the 
Figure 1. (A) The burn ulcer in diabetic patients with previous amputation surgery. B: After 10 sessions of LLLT. C: Treating the ulcer with autologous fibroblast 
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wound. Photography was done at the end of the treatment 
and the pictures were analyzed using PictZar software 
(Figure 1). Statistical analysis was carried out using IBM 
SPSS version 21. 
Results
Ten patients were recruited for this study. Of these 
patients, 7 (70%) were male and 3 (30%) were female. 
The mean age of them was 47 (SD: 12.96) years (range: 
30 to 68 years). The mean size of burn ulcers was 16.28 
cm2 (SD: 8.94 cm2). The minimum size of these ulcers 
was 8.20 cm2 and the maximum size of them was 31.03 
cm2. Of these ten ulcers, 2 (20%) healed completely after 
10 weeks, 5 (50%) remained after 11 weeks and 3 (30%) 
lasted after 12 weeks from the treatment onset.
There was no linear correlation between the time to 
complete healing and the age of the patients (Pearson’s 
r = 0.511, P = 0.131) nor was there between the time 
to complete healing and the initial size of burn ulcers 
(Pearson’s r =0.476, P = 0.165).
Discussion
In this case series for the first time, we report the effect 
of autologous fibroblast skin transplantation along with 
low-level laser irradiation in treating grade 3 burn ulcers 
in diabetic patients, candidates for split-thickness skin 
graft surgery. Complete healing occurred in all patients 
in at least 3 months. Our previous study showed that 
using LLLT after a skin graft is an effective therapeutic 
modality.14,24,25 Although the autologous skin graft is the 
gold standard for covering skin defects in deep burn 
ulcers, this method has several complications including 
the need to hospitalization, the risk of anesthesia and 
surgery, especially in patients with cardiovascular diseases, 
the limitation of the donor site in extensive burns, graft 
failure, especially in diabetic patients and donor site 
scars.26 In this study, instead of harvesting a larger area of 
skin as the donor site for grafting on the damaged area, we 
just biopsied 3 mm of the patients’ post-auricular area and 
culture fibroblast, along with LLLT. Our results showed 
complete healing in all patients in at least 3 months. 
Although this process is longer than using LLLT along 
with skin graft surgery which lasts at least 2 months,13 
it had several advantages, including treating outpatient 
without need to hospitalization, avoiding surgery and its 
risks and independence of harvesting skin for the donor 
site which sometimes forms hypertrophic scars. 
In our previous study, we irradiated an infra-red 810 
nm laser on cultured skin fibroblasts of diabetic and non-
diabetic mice. Our results showed that laser irradiation 
significantly increased the fibroblast growth factor gene 
expression in the diabetic mice. Although laser irradiation 
also increased the expression of the platelet-derived 
growth factor, it was not statistically significant.19
Cell therapy has been applied in treating burn ulcers 
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can provide an extracellular matrix, vascularization, 
and granulation tissue formation and it can support 
the epithelial layer.28 Braye et al used a widely meshed 
autograft with autologous cultured epithelium for treating 
an extensive burn in children.29 Wisser and Steffes 
reported the successful use of autologous keratinocyte 
and fibroblast in a burned patient.6 Owen et al reported 
the successful use of a tissue-engineered dermal graft 
containing neonatal skin fibroblast for the treatment of 
ulcerated necrobiosis lipoidica.30 Nilforoushzadeh et al 
reported treating a burn ulcer in diabetic patients, using 
autologous fibroblast suspension.23 They also used this 
technique for soft tissue augmentation and the treatment 
of scars and wrinkles.31
Several meta-analyses and reviews suggest LLLT as 
an effective therapeutic modality for wound healing.32-34 
Most of these clinical studies are on diabetic, venous and 
pressure ulcers32,33,35 and the effect of laser therapy on 
burn ulcers is studied only on animal models.36 Mester, 
the pioneer of using LLLT in wound healing, studied 
the effect of laser therapy on burn ulcers in mice. He 
concluded that laser irradiation stimulates the healing 
process by increasing epithelial formation.37
Dantas et al used sodium alginate/chitosan-based films 
along with LLLT for treating burn ulcers in mice. They 
reported that the combination of these two methods 
improves healing by modulating epithelialization, 
collagen formation and neovascularization.38 Bayat et al 
reported that using laser therapy on deep second-degree 
burns in rats decreased the incidence of infection with 
Staphylococcus aureus and epidermis.39 Ezzati et al 
showed that LLLT promoted the healing of third-degree 
burn ulcers in rats.40
The only clinical report was our previous study on 
the effect of LLLT on a type 3 burn ulcer in diabetic 
patients after a skin graft. We concluded that LLLT is an 
effective therapeutic modality in burn ulcers.14 Gaida et al 
reported that LLLT had positive effects on patients with 
burn scars.41
Almeida‐Lopes et al studied the effect of LLLT on the 
proliferation of cultured human gingival fibroblasts. They 
concluded that laser therapy improved the proliferation 
of fibroblasts in vitro.12 
Conclusion 
A delay in burn wound healing increases patients’ pain 
and discomfort, the rate of infection, the likelihood of 
surgical procedures and the duration of hospitalization. 
Applying autologous fibroblast skin culture along with 
LLLT may decrease these morbidities and can be used as 
an effective therapeutic modality in patients with high 
risks for surgery or those who do not agree with skin graft 
surgery.
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